Description
+ Include: 37 videos + 30 pdfs, size: 6.71 GB
+ Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees
+ Sample video: contact me for sample video
+ Information:
Date & Location: Friday, April 25, 2025, 8:00 AM – Saturday, April 26, 2025, 12:55 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
This annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking drug developments that are redefining patient care. Attendees will gain valuable insights into the latest findings in lymphoma biology and pathology, exploring how these breakthroughs are being translated into practical, impactful solutions for clinical practice.
The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the choice of attending either in-person or virtually.
We look forward to welcoming colleagues and esteemed faculty from around the world to exchange insights and advance the future of lymphoma care.
- Describe recent advances in lymphoma classification
- Discuss first line treatment options in most frequent lymphoma entities
- Describe new agents mode of actions, efficacy, side effects
- Discuss options and recommendations for patients in the relapse refractory setting
- Provide adequate information to help shared decision with patients regarding their treatment
+ Topics:
Advances in Biology.mp4
Advances in Biology.pdf
Advancing Therapeutic Options in the Relapse Setting.mp4
Advancing Therapeutic Options in the Relapse Setting.pdf
B-Cell Dynamics in the Germinal Center.mp4
B-Cell Dynamics in the Germinal Center.pdf
Biology of Hodgkin Lymphoma.mp4
Biology of Hodgkin Lymphoma.pdf
CAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.mp4
CAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.pdf
Cellular Therapies for Treating Mantle Cell Lymphoma.mp4
Cellular Therapies for Treating Mantle Cell Lymphoma.pdf
Current Dilemma in the First Line Therapy Setting.mp4
Current Dilemma in the First Line Therapy Setting.pdf
Epidemiology and Outcomes of Lymphoma.mp4
Epidemiology and Outcomes of Lymphoma.pdf
Germinal Center Biology.pdf
Histologic Transformation of Follicular Lymphoma.mp4
Histologic Transformation of Follicular Lymphoma.pdf
Lessons and Challenges.mp4
Lessons and Challenges.pdf
Lymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.mp4
Lymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.pdf
Lymphoma2025_Brochure.pdf
Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.mp4
Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.pdf
Management of Older Patients.mp4
Management of Older Patients.pdf
Mantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.mp4
Mantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.pdf
New Antibodies Engaging Immune Cells.mp4
New Antibodies Engaging Immune Cells.pdf
New Drugs on the Horizon for Follicular Lymphoma.mp4
New Drugs on the Horizon for Follicular Lymphoma.pdf
Notch and Marginal Zone Biology.mp4
Notch and Marginal Zone Biology.pdf
Optimizing First Line Therapy.mp4
Optimizing First Line Therapy.pdf
Optimizing Patient Selection in 2025.mp4
Optimizing Patient Selection in 2025.pdf
Options After First Line Treatment Failure.mp4
Options After First Line Treatment Failure.pdf
Panel Discussion- Advances in Therapeutic Strategies for Mantle Cell Lymphoma.mp4
Panel Discussion- Aggressive B-Cell Lymphoma & Car T-Cell Therapies in Large B-Cell Lymphoma.mp4
Panel Discussion- Aggressive B-Cell Lymphoma- Addressing Remaining Gaps on the Path to a Definitive Cure.mp4
Panel Discussion- Current Challenges in the Management of Patients with Follicular Lymphoma.mp4
Panel Discussion- Empowering APPs and Nurses.mp4
Panel Discussion- Hodgkin Lymphoma.mp4
Panel Discussion- Improving Outcomes of Patients with T-Cell Lymphoma.mp4
Panel Discussion- The Dark Side of B-Cells.mp4
Progress in Large B-Cell Lymphoma Management.mp4
Progress in Large B-Cell Lymphoma Management.pdf
Radiation Therapy and CAR T.mp4
Recent Insights Into Mantle Cell Lymphoma Biology.mp4
Recent Insights Into Mantle Cell Lymphoma Biology.pdf
Research Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.mp4
Research Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.pdf
Single Cell Analysis of B-Cell Lymphoma.mp4
Single Cell Analysis of B-Cell Lymphoma.pdf
The Evolving Standard of Care in First Line.mp4
The Evolving Standard of Care in First Line.pdf
Treatment Initiation Versus Active Surveillance.mp4
Treatment Initiation Versus Active Surveillance.pdf
Update on Burkitt Lymphoma.mp4
Update on Burkitt Lymphoma.pdf
Update on Primary Mediastinal B-Cell Lymphoma.mp4
Update on Primary Mediastinal B-Cell Lymphoma.pdf
Reviews
There are no reviews yet.